Aravive, Inc. 3 SEC Filings

Filed On	Filing
11 Apr 2023	Form 3: Petrini Maria Carolina, Chief Commercial Officer No securities owned
05 Jul 2022	Form 3: Geller Robert B., Chief Medical Officer No securities owned
03 Jun 2022	Form 3: Howard Rudy, Chief Financial Officer No securities owned
22 Mar 2022	Form 3: Dove Leonard Scott, Chief Operating Officer No securities owned
21 May 2021	Form 3: Kirk Sigurd, Director No securities owned
21 May 2021	Form 3: Ho Peter Tai-Ching, Director Holds 1,000 shares of Common Stock
21 May 2021	Form 3: Hohneker John, Director No securities owned
29 Sep 2020	Form 3: Rangwala Reshma, Chief Medical Officer No securities owned
17 Sep 2020	Form 3: Rogers Michael W, Director No securities owned
10 Apr 2020	Form 3: Eshelman Fredric N, Director and 1 other Holds 931,098 shares of Common Stock
09 Jan 2020	Form 3: Hemrajani Rekha, Director No securities owned
25 Feb 2019	Form 3: McIntyre Gail Frances, Chief Scientific Officer
16 Oct 2018	Form 3: Zhang Eric, Director Holds 0 shares of Common Stock
16 Oct 2018	Form 3: Shah Vinay, Chief Financial Officer Holds 0 shares of Common Stock
16 Oct 2018	Form 3: Tabibiazar Raymond, Director Holds 0 shares of Common Stock
16 Oct 2018	Form 3: Hoffman Robert, Director Holds 0 shares of Common Stock
16 Oct 2018	Form 3: Giaccia Amato, Director Holds 0 shares of Common Stock
04 Dec 2017	Form 3: Haas Kevin, VP, Finance and PAO Holds 35,117 shares of Common Stock
06 Sep 2017	Form 3: Gut Robert, Chief Medical Officer Holds 0 shares of No securities held.
06 Jun 2017	Form 3: Dobmeier Eric, Director Holds 0 shares of Common Stock

Comments